205 related articles for article (PubMed ID: 35634245)
1. NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer.
Schrank TP; Prince AC; Sathe T; Wang X; Liu X; Alzhanov DT; Burtness B; Baldwin AS; Yarbrough WG; Issaeva N
Oncotarget; 2022; 13():707-722. PubMed ID: 35634245
[TBL] [Abstract][Full Text] [Related]
2. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
3. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
Schrank TP; Kothari A; Weir WH; Stepp WH; Rehmani H; Liu X; Wang X; Sewell A; Li X; Tasoulas J; Kim S; Yarbrough G; Xie Y; Flamand Y; Marur S; Hayward MC; Wu D; Burtness B; Anderson KS; Baldwin AS; Yarbrough WG; Issaeva N
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216532120. PubMed ID: 37523561
[TBL] [Abstract][Full Text] [Related]
4. Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
Zhang J; Chen T; Yang X; Cheng H; Späth SS; Clavijo PE; Chen J; Silvin C; Issaeva N; Su X; Yarbrough WG; Annunziata CM; Chen Z; Van Waes C
Cancer Res; 2018 Aug; 78(16):4613-4626. PubMed ID: 29921694
[TBL] [Abstract][Full Text] [Related]
5. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
[TBL] [Abstract][Full Text] [Related]
6. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
[TBL] [Abstract][Full Text] [Related]
7. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
[TBL] [Abstract][Full Text] [Related]
8. CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features.
Williams EA; Montesion M; Alexander BM; Ramkissoon SH; Elvin JA; Ross JS; Williams KJ; Glomski K; Bledsoe JR; Tse JY; Mochel MC
Mod Pathol; 2021 Feb; 34(2):358-370. PubMed ID: 32892208
[TBL] [Abstract][Full Text] [Related]
9. TRAF3 and NBR1 both influence the effect of the disease-causing CYLD(Arg936X) mutation on NF-κB activity.
Danis J; Kelemen E; Rajan N; Nagy N; Széll M; Ádám É
Exp Dermatol; 2021 Nov; 30(11):1705-1710. PubMed ID: 33999445
[TBL] [Abstract][Full Text] [Related]
10. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.
Li YY; Chung GT; Lui VW; To KF; Ma BB; Chow C; Woo JK; Yip KY; Seo J; Hui EP; Mak MK; Rusan M; Chau NG; Or YY; Law MH; Law PP; Liu ZW; Ngan HL; Hau PM; Verhoeft KR; Poon PH; Yoo SK; Shin JY; Lee SD; Lun SW; Jia L; Chan AW; Chan JY; Lai PB; Fung CY; Hung ST; Wang L; Chang AM; Chiosea SI; Hedberg ML; Tsao SW; van Hasselt AC; Chan AT; Grandis JR; Hammerman PS; Lo KW
Nat Commun; 2017 Jan; 8():14121. PubMed ID: 28098136
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.
Chen T; Zhang J; Chen Z; Van Waes C
Cancer; 2017 May; 123(10):1695-1698. PubMed ID: 28295216
[TBL] [Abstract][Full Text] [Related]
12. CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.
Cui Z; Kang H; Grandis JR; Johnson DE
Mol Cancer Res; 2021 Jan; 19(1):14-24. PubMed ID: 32883697
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
Mainguené J; Vacher S; Kamal M; Hamza A; Masliah-Planchon J; Baulande S; Ibadioune S; Borcoman E; Cacheux W; Calugaru V; Courtois L; Crozes C; Deloger M; Girard E; Delord JP; Dubray-Vautrin A; Larbi Chérif L; Dupain C; Jeannot E; Klijanienko J; Lameiras S; Lecerf C; Modesto A; Nicolas A; Rouzier R; Saada-Bouzid E; Saintigny P; Sudaka A; Servant N; Le Tourneau C; Bièche I
Mol Oncol; 2022 Aug; 16(16):3001-3016. PubMed ID: 35398964
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus, tobacco, and poor oral hygiene can act synergetically, modulate the expression of the nuclear factor kappa B signaling pathway for the development and progression of head and neck cancer in the Pakistani population.
Sarwar S; Mulla M; Mulla M; Tanveer R; Sabir M; Sultan A; Malik SA
Chin Med J (Engl); 2022 Aug; 135(15):1829-1836. PubMed ID: 35838554
[TBL] [Abstract][Full Text] [Related]
15. Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
Yang X; Cheng H; Chen J; Wang R; Saleh A; Si H; Lee S; Guven-Maiorov E; Keskin O; Gursoy A; Nussinov R; Fang J; Van Waes C; Chen Z
Cancer Immunol Res; 2019 Nov; 7(11):1760-1774. PubMed ID: 31624067
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.
Hinić S; Rich A; Anayannis NV; Cabarcas-Petroski S; Schramm L; Meneses PI
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142875
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
[TBL] [Abstract][Full Text] [Related]
18.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
